✦ LIBER ✦

Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study

✍ Scribed by Joanna Sańko-Resmer; Olivier Boillot; Philippe Wolf; Douglas Thorburn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Conversion from T

✍ Y. Nakamura; K. Hama; H. Katayama; A. Soga; T. Toraishi; T. Yokoyama; Y. Kihara; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 693 KB

Efficacy and Safety of Conversion from T

✍ L. Guirado; C. Cantarell; A. Franco; E. G. Huertas; A. S. Fructuoso; A. Fernánde 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Efficacy, safety, and immunosuppressant

✍ Susanne Beckebaum; Speranta Iacob; Dani Sweid; Georgios C. Sotiropoulos; Fuat Sa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

An open-label, pilot study evaluating th

✍ V Ram Peddi; Stephen Jensik; Mark Pescovitz; John Pirsch; Scott H Adler; J Richa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Study 1: an open-label pilot study evalu

✍ V.Ram Peddi; David J. Cohen; M.Roy First 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB